Bio Preventive Medicine Corp. Obtained Malaysia MDA Approval for Diabetic Kidney Disease Preventive Detection Kit “DNlite-IVD103”

Bio Preventive Medicine Corporation (BPM), a leading-edge In Vitro Diagnostics (IVD) company, announced on Aug. 31th, 2020, that their diagnostic kit DNlite-IVD103 has obtained MDA approval in Malaysia and ready to enter ASEAN market.

For those interested in learning more about DNlite-IVD103 in person, BPM will be exhibiting at the EASD 2020 virtual exhibition ( from September 21st till the 25th at Hall Rome/ No.10